Sasaki-Hamada S - Search Results

1

LARETH-25 and β-CD improve central transitivity and central pharmacological effect of the GLP-2 peptide.

Nakao Y, Horiguchi M, Nakamura R, Sasaki-Hamada S, Ozawa C, Funane T, Ozawa R, Oka JI, Yamashita C. Nakao Y, et al. Int J Pharm. 2016 Dec 30;515(1-2):37-45. doi: 10.1016/j.ijpharm.2016.09.054. Epub 2016 Oct 5. Int J Pharm. 2016. PMID: 27720872

2

Antidepressant-like effects exerted by the intranasal administration of a glucagon-like peptide-2 derivative containing cell-penetrating peptides and a penetration-accelerating sequence in mice.

Sasaki-Hamada S, Nakamura R, Nakao Y, Akimoto T, Sanai E, Nagai M, Horiguchi M, Yamashita C, Oka JI. Sasaki-Hamada S, et al. Peptides. 2017 Jan;87:64-70. doi: 10.1016/j.peptides.2016.11.013. Epub 2016 Nov 25. Peptides. 2017. PMID: 27894924

3

Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice.

Iwai T, Ohnuki T, Sasaki-Hamada S, Saitoh A, Sugiyama A, Oka J. Iwai T, et al. Behav Brain Res. 2013 Apr 15;243:153-7. doi: 10.1016/j.bbr.2013.01.010. Epub 2013 Jan 16. Behav Brain Res. 2013. PMID: 23333402

4

Characterization of the hypotensive effects of glucagon-like peptide-2 in anesthetized rats.

Iwai T, Kaneko M, Sasaki-Hamada S, Oka J. Iwai T, et al. Neurosci Lett. 2013 Aug 29;550:104-8. doi: 10.1016/j.neulet.2013.07.004. Epub 2013 Jul 15. Neurosci Lett. 2013. PMID: 23867714

5

Glucagon-like peptide-2-induced memory improvement and anxiolytic effects in mice.

Iwai T, Jin K, Ohnuki T, Sasaki-Hamada S, Nakamura M, Saitoh A, Sugiyama A, Ikeda M, Tanabe M, Oka J. Iwai T, et al. Neuropeptides. 2015 Feb;49:7-14. doi: 10.1016/j.npep.2014.11.001. Epub 2014 Nov 24. Neuropeptides. 2015. PMID: 25481797

6

Intranasal administration of neuromedin U derivatives containing cell-penetrating peptides and a penetration-accelerating sequence induced memory improvements in mice.

Sasaki-Hamada S, Funane T, Nakao Y, Sasaki R, Nagai M, Ueta Y, Yoshizawa K, Horiguchi M, Yamashita C, Oka JI. Sasaki-Hamada S, et al. Peptides. 2018 Jan;99:241-246. doi: 10.1016/j.peptides.2017.10.010. Epub 2017 Oct 25. Peptides. 2018. PMID: 29079533

7

Effects of centrally administered glucagon-like peptide-2 on blood pressure and barosensitive neurons in spontaneously hypertensive rats.

Sasaki-Hamada S, Narusawa K, Nakamura R, Ishibashi H, Oka JI. Sasaki-Hamada S, et al. Neuropeptides. 2018 Jun;69:66-75. doi: 10.1016/j.npep.2018.04.007. Epub 2018 Apr 18. Neuropeptides. 2018. PMID: 29703428

8

Pharmacological evidence for the relationship between the NMDA receptor and nitric oxide pathway and the antidepressant-like effects of glucagon-like peptide-2 in the mouse forced-swim test.

Sasaki-Hamada S, Nakamura Y, Koizumi K, Nabeta R, Oka JI. Sasaki-Hamada S, et al. Behav Brain Res. 2019 May 17;364:162-166. doi: 10.1016/j.bbr.2019.02.028. Epub 2019 Feb 16. Behav Brain Res. 2019. PMID: 30779973

9

Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin.

Sasaki-Hamada S, Ikeda M, Oka JI. Sasaki-Hamada S, et al. Sci Rep. 2019 Sep 23;9(1):13723. doi: 10.1038/s41598-019-50167-3. Sci Rep. 2019. PMID: 31548563 Free PMC article.

10

GLP-2 restores impairments in spatial working memory and hippocampal LTD via the MEK/ERK pathway in juvenile-onset diabetes rats.

Sasaki-Hamada S, Fujiwara A, Satoh S, Iwai T, Oka JI. Sasaki-Hamada S, et al. Behav Brain Res. 2021 May 21;406:113235. doi: 10.1016/j.bbr.2021.113235. Epub 2021 Mar 11. Behav Brain Res. 2021. PMID: 33716118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters